Dystroglycan is Required for Proper Retinal Layering
Overview
Reproductive Medicine
Affiliations
Dystroglycan (DG) is a transmembrane receptor linking the extracellular matrix to the internal cytoskeleton. Its structural function has been mainly characterized in muscle fibers, but DG plays signaling and developmental roles also in different tissues and cell types. We have investigated the effects of dystroglycan depletion during eye development of Xenopus laevis. We have injected a specific morpholino (Mo) antisense oligonucleotide in the animal pole of one dorsal blastomere of embryos at four cells stage. Mo-mediated loss of DG function caused disruption of the basal lamina layers, increased apoptosis and reduction of the expression domains of specific retinal markers, at early stages. Later in development, morphants displayed unilateral ocular malformations, such as microphtalmia and retinal delayering with photoreceptors and ganglion cells scattered throughout the retina or aggregated in rosette-like structures. These results recall the phenotypes observed in specific human diseases and suggest that DG presence is crucial at early stages for the organization of retinal architecture.
Retinogenesis of the Human Fetal Retina: An Apical Polarity Perspective.
Quinn P, Wijnholds J Genes (Basel). 2019; 10(12).
PMID: 31795518 PMC: 6947654. DOI: 10.3390/genes10120987.
The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy.
Nickolls A, Bonnemann C Dis Model Mech. 2018; 11(12).
PMID: 30578246 PMC: 6307911. DOI: 10.1242/dmm.035931.
Laminin β2 Chain Regulates Retinal Progenitor Cell Mitotic Spindle Orientation via Dystroglycan.
Serjanov D, Bachay G, Hunter D, Brunken W J Neurosci. 2018; 38(26):5996-6010.
PMID: 29853630 PMC: 6021997. DOI: 10.1523/JNEUROSCI.0551-18.2018.
Dystroglycan Maintains Inner Limiting Membrane Integrity to Coordinate Retinal Development.
Clements R, Turk R, Campbell K, Wright K J Neurosci. 2017; 37(35):8559-8574.
PMID: 28760865 PMC: 5577860. DOI: 10.1523/JNEUROSCI.0946-17.2017.
Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy.
Sciandra F, Bigotti M, Giardina B, Bozzi M, Brancaccio A Biomed Res Int. 2015; 2015:635792.
PMID: 26380289 PMC: 4561298. DOI: 10.1155/2015/635792.